Tags

Type your tag names separated by a space and hit enter

Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.
Psychosom Med. 2004 Nov-Dec; 66(6):837-44.PM

Abstract

OBJECTIVE

The prevalence as well as predictors of psychiatric disorders (Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] axis I and II) in patients with fibromyalgia syndrome (FMS) was evaluated.

METHOD

One-hundred fifteen patients with FMS participated in the Structured Clinical Interview for DSM-IV to assess current mental disorders. In addition, patients completed standardized questionnaires regarding pain, pain impact, anxiety, depression, posttraumatic stress disorder-like symptoms, and sexual and physical abuse.

RESULTS

Patients were grouped into one of three psychosocial subgroups based on responses to the Multidimensional Pain Inventory (MPI)-Dysfunctional (DYS), Interpersonally Distressed (ID), and Adaptive Copers (AC). Axis I diagnoses were present in 74.8% of the participants overall with the DYS subgroup mainly reporting anxiety and the ID group mood disorders. The AC group showed little comorbidity. Axis II diagnoses were present in only 8.7% of the FMS sample.

CONCLUSION

These results suggest that FMS is not a homogeneous diagnosis, but shows varying proportions of comorbid anxiety and depression dependent on psychosocial characteristics of the patients. The results demonstrate the importance of not treating patients with FMS as a homogeneous group. Assessment should not only examine the presence of widespread pain and the number of tender points, but also the presence of affective distress. Treatment should focus both on physical and emotional dysfunction.

Authors+Show Affiliations

Department of Anesthesiology at the University of Washington, 1959 NE Pacific Street, Box 356540, Seattle, WA 98195-6540, USA. thiemek@u.washington.eduNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15564347

Citation

Thieme, Kati, et al. "Comorbid Depression and Anxiety in Fibromyalgia Syndrome: Relationship to Somatic and Psychosocial Variables." Psychosomatic Medicine, vol. 66, no. 6, 2004, pp. 837-44.
Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004;66(6):837-44.
Thieme, K., Turk, D. C., & Flor, H. (2004). Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosomatic Medicine, 66(6), 837-44.
Thieme K, Turk DC, Flor H. Comorbid Depression and Anxiety in Fibromyalgia Syndrome: Relationship to Somatic and Psychosocial Variables. Psychosom Med. 2004 Nov-Dec;66(6):837-44. PubMed PMID: 15564347.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. AU - Thieme,Kati, AU - Turk,Dennis C, AU - Flor,Herta, PY - 2004/11/27/pubmed PY - 2005/9/1/medline PY - 2004/11/27/entrez SP - 837 EP - 44 JF - Psychosomatic medicine JO - Psychosom Med VL - 66 IS - 6 N2 - OBJECTIVE: The prevalence as well as predictors of psychiatric disorders (Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] axis I and II) in patients with fibromyalgia syndrome (FMS) was evaluated. METHOD: One-hundred fifteen patients with FMS participated in the Structured Clinical Interview for DSM-IV to assess current mental disorders. In addition, patients completed standardized questionnaires regarding pain, pain impact, anxiety, depression, posttraumatic stress disorder-like symptoms, and sexual and physical abuse. RESULTS: Patients were grouped into one of three psychosocial subgroups based on responses to the Multidimensional Pain Inventory (MPI)-Dysfunctional (DYS), Interpersonally Distressed (ID), and Adaptive Copers (AC). Axis I diagnoses were present in 74.8% of the participants overall with the DYS subgroup mainly reporting anxiety and the ID group mood disorders. The AC group showed little comorbidity. Axis II diagnoses were present in only 8.7% of the FMS sample. CONCLUSION: These results suggest that FMS is not a homogeneous diagnosis, but shows varying proportions of comorbid anxiety and depression dependent on psychosocial characteristics of the patients. The results demonstrate the importance of not treating patients with FMS as a homogeneous group. Assessment should not only examine the presence of widespread pain and the number of tender points, but also the presence of affective distress. Treatment should focus both on physical and emotional dysfunction. SN - 1534-7796 UR - https://www.unboundmedicine.com/medline/citation/15564347/Comorbid_depression_and_anxiety_in_fibromyalgia_syndrome:_relationship_to_somatic_and_psychosocial_variables_ L2 - https://doi.org/10.1097/01.psy.0000146329.63158.40 DB - PRIME DP - Unbound Medicine ER -